Skip to content

Role of Ultrasound Assessment of Parasternal Intercostal Muscle Thickness During Weaning From Mechanical Ventilation

Role of Ultrasound Assessment of Parasternal Intercostal Muscle Thickness During Weaning From Mechanical Ventilation

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04779463
Enrollment
40
Registered
2021-03-03
Start date
2020-06-01
Completion date
2021-04-01
Last updated
2021-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parasternal Intercostal Muscle Thickness, Weaning From Mechanical Ventilation

Keywords

mechanical ventilation, parasternal muscle thickness

Brief summary

Assessment of the the parasternal intercostal muscles thickness by the ultrasonography as a weaning predictor of the mechanically ventilated patients

Detailed description

impact of parasternal muscle thickness on the weaning process of the mechanically ventilated patients in ICU

Interventions

DIAGNOSTIC_TESTParasternal intercostal muscles thickness ultrasound indicies

Parasternal intercostal muscles thickness ultrasound indicies includes: * Parasternal Intercostals Thickness Fraction. * Parasternal Intercostals Thickness at the End of Inspiration. * Parasternal Intercostals thickness at the End of Expiration.

Sponsors

Wesameldin Abelrahman Soltan
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

Any patient invasively mechanically ventilated at least 24 hours on a pressure support mode who is clinically stable and ready to undergo a spontaneous breathing trial. All patients will be: * Alert. * Afebrile. * Adequate cough with absence of excessive tracheobronchial secretion. * Fraction of inspired oxygen (FIO2) of \<50%. * PEEP ≤8 cmH2O. * PaO2/FiO2 \> 150. * pH ≥7.35 and ≤7.45. * Respiratory rate (RR) ≤35 breaths/min. * Hemodynamically stable in the absence of vasopressors. * Stable metabolic and endocrinal status. * Euglycemic state. * Adequate mentation (no sedation or stable neurologic patient).

Exclusion criteria

Diaphragmatic paralysis (detected by ultrasonography).Patients&Methods. 6 * Pregnant women. * Age: \>= 18 years. * Surgical dressings over measurement point which would preclude ultrasound exam. * Underweight patients (Body mass index \<18.5 kg/m2). * Morbidly obese patient (Body mass index ≥ 40 kg/m2). * Primary neuro-muscular diseases. * Central coditions with depressed central respiratory drive (encephalitis, and brainstem haemorrhage/ischaemia). * Repiratory conditions with reduced pulmonary compliance (interstitial lung disease, pulmonary hemorrhage, and diffuse pulmonary infiltrates) or reduced chest wall compliance (kyphoscoliosis). * Cardiac conditions with high risk of weaning induced pulmonary edema (congestive heart failure, cyanotic heart diease, pulmonary hypertension, and ischemic heart diease). * Addict patients. * Patients with psychiatric disease.

Design outcomes

Primary

MeasureTime frameDescription
the thickness fraction of the parasternal intercostal muscle as a predictor of successful spontaneous breathing trialsBefore the start spontaneous breathing trialThe primary outcome is to assess the change of the parasternal intercostal muscles thickness at end of expiration and end of inspiration to verify the thickness fraction of the parasternal intercostal muscle as a predictor of successful spontaneous breathing trials.

Countries

Egypt

Contacts

Primary ContactWesameldin A Soltan, M.D.
wesamsultan1@gmail.com0020101012215

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026